Key Points
-
The sale was valued at $120,400.
-
The transaction size represents 6% of the equity holdings Rapp maintained prior to the filing.
-
The shares were sold directly by Rapp under a Rule 10b5-1 trading plan.
- 10 stocks we like better than Plexus ›
Karen Marie Rapp, Director of Plexus (NASDAQ:PLXS), reported a sale of 500 shares of common stock on Aug. 31, 2026, according to a recent SEC Form 4 filing.
Transaction summary
MetricValueShares sold500Transaction value$120,435Post-transaction shares (directly held)7,535Post-transaction value$1.8 million
Transaction value based on SEC Form 4 weighted average sale price ($240.87); post-transaction value based on Aug. 31, 2026, market close ($239.47).
Key questions
- What was the structural nature of this transaction?
The sale was non-discretionary, executed through a Rule 10b5-1 trading plan. These plans are designed to allow corporate insiders to schedule share sales in advance, providing a structured mechanism for liquidity while operating within regulatory guidelines. - How does this disposal impact Rapp’s long-term equity position?
Following the sale of 500 shares, Rapp continues to hold 7,535 shares directly. This remaining equity stake is valued at $1.8 million based on the market close on Aug. 31, 2026. - What is the broader context of insider ownership at the company?
Total insider ownership in the company is currently 0.02%. Plexus, which specializes in advanced electronic manufacturing solutions, maintains a market capitalization of $6.8 billion and reported trailing twelve-month revenue of $4.6 billion as of the latest reporting period.
Company Overview
MetricValueShare Price (as of market close 2026-08-31)$239.47Market Capitalization$6.8 billionRevenue (TTM)$4.6 billionNet Income (TTM)$185.4 million
Company Snapshot
- Plexus provides comprehensive electronic manufacturing solutions, including design and development, supply chain management, new product introduction support, core manufacturing capabilities, and aftermarket services to clients across multiple industries.
- The company operates a vertically integrated business model that generates revenue through design services, manufacturing operations, supply chain optimization, and value-added aftermarket support, serving as a critical partner throughout the product lifecycle.
- Plexus serves a diverse customer base across industrial, healthcare, aerospace, defense, and telecommunications sectors, with a global operational footprint spanning the Americas, Europe, the Middle East, Africa, and the Asia-Pacific regions.
Plexus is a global electronics manufacturing services provider with approximately 20,000 employees and $4.6 billion in TTM revenue, positioning it as a significant player in the advanced manufacturing sector. The company’s differentiated value proposition centers on its ability to deliver end-to-end solutions from design through manufacturing and aftermarket support, enabling customers to accelerate time-to-market while optimizing operational efficiency. With a market capitalization of $6.4 billion and demonstrated operational leverage, Plexus maintains a competitive advantage through its integrated service offerings and established relationships with leading technology and industrial companies worldwide.
What this transaction means for investors
On Aug. 31, Rapp sold 500 shares, with the transaction being valued at approximately $120,000. However, looking at several details of the transaction doesn’t indicate anything that should worry shareholders. For starters, the plan to sell these shares was established in February 2026. That means this sale was made on a spur-of-the-moment decision. In addition, although Rapp sold 500 shares, the insider still holds 7,535 shares, indicating continued alignment with Plexus’s success. Finally, the stock price has performed exceptionally well over the past 12 months.
Shares of Plexus are up nearly 85% over the last year, while the S&P 500 is up 16.2% over the same period. So, while the sale was conducted under an established plan, even if it wasn’t, it makes sense that an insider might consider taking some gains off the table given the stock’s strong performance. When all of that is added together, this sale appears to be just a routine transaction.
Should you buy stock in Plexus right now?
Before you buy stock in Plexus, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Plexus wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $417,413!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,341,294!*
Now, it’s worth noting Stock Advisor’s total average return is 950% — a market-crushing outperformance compared to 210% for the S&P 500. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of September 12, 2026.
Jack Delaney has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
